Positive predictive value (PPV) tells you the probability that a positive test result is actually correct. If a screening test comes back positive, PPV answers the natural follow-up question: “What are the chances I actually have this condition?” A PPV of 80% means that out of every 100 people who test positive, 80 truly have the disease and 20 are false alarms.
How PPV Is Calculated
The formula is straightforward. You divide the number of true positives by the total number of positive results (true positives plus false positives):
PPV = true positives / (true positives + false positives)
A “true positive” is someone who tested positive and actually has the condition. A “false positive” is someone who tested positive but does not have it. The more false positives a test produces, the lower its PPV drops, because a larger share of positive results are wrong.
Why Prevalence Changes Everything
Here is the part that surprises most people: the same test, with the exact same accuracy, can have a dramatically different PPV depending on how common the disease is in the population being tested. This is the single most important thing to understand about PPV.
A real-world example makes this concrete. Researchers studied a prostate cancer screening marker with 98% sensitivity and 16% specificity across a group of 2,162 men. When the disease prevalence was 23% (the actual study population), the PPV was 26%, meaning roughly one in four positive results indicated real cancer. When they modeled the same test in a population where prevalence was 50%, PPV jumped to 54%. And when prevalence dropped to just 10%, PPV fell to 11%, meaning nearly 9 out of 10 positive results were false alarms. The sensitivity and specificity of the test did not change at all across these scenarios.
The logic is intuitive once you see it. In a rare disease, the vast majority of people being tested don’t have the condition. Even a small false positive rate, applied to that huge group of healthy people, generates a flood of incorrect positive results that overwhelms the small number of true positives. In a common disease, there are enough genuinely sick people that true positives make up a bigger share of all positives.
PPV vs. Sensitivity and Specificity
Sensitivity measures how well a test catches people who actually have a disease. Specificity measures how well it correctly identifies people who don’t. Both are properties of the test itself and stay relatively stable no matter who you test.
PPV is different. It is not a fixed property of the test. It shifts with the population. A test used in a high-risk group (say, people already showing symptoms) will have a higher PPV than the identical test used for routine screening in healthy people. This is why a positive result from a screening test often leads to a second, confirmatory test rather than an immediate diagnosis.
Real-World Examples
Mammography illustrates how widely PPV can vary in practice. Published PPV values for mammographic biopsy recommendations range from as low as 4.3% to as high as 52.4%, depending on the radiologist, the patient population, and the threshold used for calling a result abnormal. That enormous range explains why most women who are called back after a screening mammogram ultimately learn they do not have cancer.
COVID-19 rapid antigen tests showed the same pattern during the pandemic. For people without symptoms using a rapid test when community prevalence was just 0.5%, the PPV dropped to around 50 to 60%. That means a positive result was essentially a coin flip. Over 40% of the time, the “positive” was wrong. The same test performed during a major outbreak, when prevalence was high, would have a far more reliable positive result.
PSA testing for prostate cancer offers another example. At very high PSA levels (above 20 ng/mL), the PPV for metastatic disease is about 65%. At levels above 100 ng/mL, it climbs to 86%. The higher the threshold for calling a result “positive,” the fewer false positives slip through, and the PPV rises.
The Bayes’ Theorem Connection
PPV is actually an application of Bayes’ theorem, the foundational formula in probability for updating your beliefs based on new evidence. The full equation expresses PPV in terms of three inputs: the test’s sensitivity, its specificity, and the prevalence of the disease:
PPV = (sensitivity × prevalence) / [(sensitivity × prevalence) + ((1 − specificity) × (1 − prevalence))]
This formula makes the prevalence dependency explicit. The numerator captures how many true positives you’d expect. The denominator adds in the false positives generated by testing all the healthy people. When prevalence is tiny, that second term in the denominator dominates, dragging PPV down. You don’t need to memorize this formula, but understanding its structure explains why testing low-risk populations for rare conditions so often produces misleading positive results.
What PPV Means for You
If you’ve received a positive test result and want to know how worried to be, PPV is the number that matters most. But you usually won’t find it printed on your lab report, because it depends on your personal risk profile, not just the test’s technical specs. Your risk factors, symptoms, family history, and the prevalence of the condition in people like you all feed into how likely it is that your positive result is a true positive.
This is exactly why doctors often order follow-up tests after an initial positive screening. The first test raises suspicion. The second test, applied to a now higher-risk group (people who already tested positive once), has a much higher PPV. Each round of testing narrows the pool and increases confidence in the result.
When evaluating any screening test or diagnostic claim, asking “What’s the positive predictive value?” is more useful than asking “How accurate is this test?” Accuracy, sensitivity, and specificity describe the test in isolation. PPV tells you what a positive result actually means for the person sitting in the chair.